ABL, an Institut Mérieux company
ABL is a global CDMO and CRO specializing in viral vector development and manufacturing, immunological testing in support of vaccines, cell and gene therapies and other immunotherapies. Our mission is to accelerate the development of our clients' therapies, from preclinical phases to market. CDMO services include process development, validation, bulk drug substance, aseptic fill/finish and bioanalytical testing. CRO services include sample processing, immune response characterization, phenotypic and functional assays, PCR & virological assays, cytokine profiling.